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Starting from N-aryl 2-aroylhydrazono-propanehydrazonoyl chlorides, a series of new func-
tionalized 1,3,4-thiadiazoles were prepared. The structures of the compounds prepared were
conﬁrmed by both elemental and spectral analyses as well as by alternate synthesis. The mech-
anisms of the studied reactions are outlined. The antimicrobial activities of the compounds pre-
pared were screened and the results showed that most of such compounds exhibit considerable
activities.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Cairo University.Introduction
The chemistry of hydrazonoyl halides of the general formula,
RAC(X)‚NNHR’, 1, has attracted the interest of many
research groups since their discovery in 1882 [1]. Their reac-tions with various reagents and their applications in synthesis
of various heterocyclic compounds have been extensively
reviewed by Shawali and/or his colleagues [2–14] and others
[15,16]. A survey of literature reveals the presence of two con-
tradicting reports [17–19]. In one report [17], it was indicated
that reaction of N-aryl 2-oxopropane-hydra-zonoyl bromide
2a with acylhydrazines 3 yielded the corresponding substitution
products 4 which upon oxidation afforded the corresponding
formazan derivatives 5 (Scheme 1). In contrast, it was recently
reported that reaction ofN-aryl 2-oxopropanehydrazonoyl chlo-
rides 2b with acylhydrazines 3 yielded the condensation products
6 [18,19] (Scheme 1). In an attempt to provide further evidence
for the actual pathway for the reaction of 2b with acid
Scheme 1
886 A.O. Abdelhamid et al.hydrazides, it was thought interesting to study the reaction of
the products 6 with some sulfur dipolarophiles. This is because
products of type 6 still have the hydrazonoyl chloride moiety.
Our objective after such a study was to explore the utility of
compounds of type 6 as precursors in syntheses of new thi-
adiazoline derivatives of expected biological activities. This is
because many 1,3,4-thiadiazoles have been reported to possess
several biological activities such as anticancer, antihistaminic
and hypoglycemic activities [20–22].
Experimental
All melting points were measured on Electrothermal IA 9000
series digital melting point apparatus. The IR spectra were
recorded in potassium bromide disks on a Pye Unicam SP
3300 and Shimadzu FT IR 8101 PC infrared spectrophotome-
ter. 1HNMR (300 MHz) was run in deuterated dimethyl sulfox-
ide (DMSO-d6). Chemical shifts were related to that of the
solvent. Mass Spectra were recorded on a Shimadzu GCMS-
QP1000 EX mass spectrometer at 70 eV. Elemental analyses
were carried out at theMicroanalytical Center of Cairo Univer-
sity, Giza, Egypt. All reactions were followed by TLC (Silica
gel, Aluminum Sheets 60 F254, Merck). 2-(2-benzoylhydrazon-
o)-N0-phenylpropanehydrazonoyl chloride 6a, 2-(2-ben-
zoylhydrazono)-N0-p-tolylpropanehydrazonoyl chloride 6b, 2-
(2-(4-methylbenzoyl)hydrazono)-N0-(p-tolyl)propanehydrazo-
noyl chloride 6c, methyl N-phenyldithiocarbamate, methyl
benzylidenedithiocarbazate, methyl dithiocarbazate, methyl
benzoylcarbodithioate, and 5-phenyl-1,3,4-oxadiazole-2-thiol
were prepared as reported in the literature [18,19,23,24].
Synthesis of phenyl 2-(2-benzoylhydrazono)-N0-
phenylpropanehydrazonothioate (7)
Method A
A mixture of 6 (0.31 g, 1 mmol) and sodium thiophenolate
(0.13 g, 1 mmol) in ethanol (20 mL) was stirred at rt for 2 h,
and the solid formed was ﬁltered off, washed with ethanol,
dried and recrystallized from ethanol to give 7 as yellow crys-
tals (94%); m.p. 180–182 C (EtOH); IR: v 1591 (C‚N), 1653
(C‚O), 3193, 3443 (2NH) cm1; 1H NMR (DMSO-d6): d 2.19
(s, 3H, CH3), 6.90–7.89 (m, 15H, ArH’s), 9.81 (s, br, 1H, NH),12.58 (s, br, 1H, NH); Anal. Calcd for C22H20N4OS (388.49):
C, 68.02; H, 5.19; N, 14.42; S, 8.25 Found C, 68.14; H, 5.21;
N, 14.23; S, 8.34%.
Method B
A mixture of 8 (0.27 g, 1 mmol) and benzoylhydrazide (0.13 g,
1 mmol) in ethanol (20 mL) was heated under reﬂux for 2 h,
allowed to cool and the solid formed was ﬁltered off, washed
with ethanol, dried and recrystallized from ethanol to give
product in 78% yield identical in all aspects (mp., mixed mp.
and spectra data) with 7 obtained by method A.
Synthesis of phenyl 2-oxo-N0-phenylpropanehydrazonothioate
(8)
A mixture of 2b (0.19 g, 1 mmol) and sodium thiophenolate
(0.13 g, 1 mmol) in ethanol (30 mL) was stirred at rt for 1 h,
and then it was left overnight. The solid precipitate formed
was ﬁltered off, dried and crystallized from ethanol to give
the corresponding product 8 as yellow crystals (83%); m.p.
118 C (AcOH). IR: m 3264 (NH), 1659 (CO), 1600 (C‚N)
cm1. 1H NMR (DMSO-d6): d 2.33 (s, 3H, CH3), 6.90–7.41
(m, 10H, ArH’s), 9.87 (s, br., 1H, NH). Anal. Calcd for C15-
H14N2OS (270.35): C, 66.64; H, 5.22; N, 10.36; S, 11.86.
Found C, 66.59; H, 5.10; N, 10.28; S, 11.68%.
Synthesis of iminothiadiazolines 9a,b
Method A
A mixture of the appropriate 6 (5 mmol) and potassium thio-
cyanate (0.6 g, 6 mmol) in ethanol (25 mL) was stirred at rt for
24 h. The resulting solid was collected, washed with water, and
crystallized from ethanol to give the corresponding product 9.
Method B
A mixture of the appropriate 6 (0.005 mol) and thiourea
(0.38 g, 5 mmol) in ethanol (25 mL) was reﬂuxed for 3 h. The
solid product that formed after cooling was collected and crys-
tallized from ethanol to give the corresponding product 9 in
75% yield which proved identical in all aspects with that
obtained by method A.
Synthesis of new functionalized 1,3,4-thiadiazoles 887N0-(1-(5-Imino-4-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-
yl)ethylidene)-benzo-hydrazide (9a)
Yellow solid (78%); m.p. 210–2 C (EtOH); IR: v 1600
(C‚N), 1658 (C‚O), 3308, 3184 (2NH) cm1; 1H NMR
(DMSO-d6): d 2.32 (3H, s, CH3), 6.90–7.90 (10H, m, ArH’s),
10.13 (1H, s, NH), 10.83 (1H, s, NH); 13C NMR: d 13.4
(CH3), 126.2, 128.1, 128.9, 130.2, 130.8, 134.5, 140.1, 148.4,
155.3, 161.5, 165.2; MS m/z (%): 338 (M++1, 5), 337 (M+,
32), 278 (33), 161 (19), 105 (100), 77 (100). Anal. Calcd for C17-
H15N5OS (337.40): C, 60.52; H, 4.48; N, 20.76. Found C,
60.58; H, 4.40; N, 20.56%.
N0-(1-(5-Imino-4-(p-tolyl)-4,5-dihydro-1,3,4-thiadiazol-2-
yl)ethylidene)-benzo-hydrazide (9b)
Yellow solid (72%); m.p. 210 C (EtOH); IR: v 1610 (C‚N),
1674 (C‚O), 3169, 3310 (2NH) cm1; 1H NMR (DMSO-d6):
d 2.31 (3H, s, CH3), 2.50 (3H, s, CH3), 6.63–8.19 (10H, m,
ArH’s), 10.63 (1H, s, NH), 11.37 (1H, s, NH); 13C NMR: d
13.4, 21.1, 121.1, 128.6, 129.9, 131.5, 134.6, 140.4, 148.4,
155.4, 161.4, 164.8; MS m/z (%): 352 (M++1, 4), 351 (M+,
14), 161 (12), 105 (100), 77 (54). Anal. Calcd for C18H17N5OS
(351.43): C, 61.52; H, 4.88; N, 19.93. Found C, 61.46; H, 4.92;
N, 19.69%.
Preparation of the N-nitroso derivatives 10a,b
A cold saturated solution of sodium nitrite (10 mL) was added
dropwise to a solution of the appropriate 9 (1 g) in acetic acid
(20 mL) in an ice bath while stirring. The reaction mixture was
stirred for 30 min. The resulting solid was collected, washed
with water, and crystallized from acetone to give the corre-
sponding 10a and 10b, respectively.
N0-(1-[5-(nitrosoimino)-4-phenyl-4,5-dihydro-1,3,4-thiadiazol-
2-yl]ethylidene)benzohydrazide (10a)
Orange solid (69%); m.p. 187–9 C; IR: v 1581 (N‚O), 1640
(C‚N), 1681 (C‚O), 3442 (NH) cm1; 1H NMR (DMSO-
d6): d 2.29 (3H, s, CH3), 6.63–8.18 (10H, m, ArH’s), 10.63
(1H, s, NH); 13C NMR (DMSO-d6): d 1.3.4, 126.5, 127.4,
128.9, 130.2, 123.8, 134.7, 139.8, 155.7, 160.9, 161.8, 165.1;
MS m/z (%): 367 (M++1, 4), 367 (M+, 16), 314 (8), 278
(32), 161 (15), 105 (100), 77 (73). Anal. Calcd for C17H14N6O2S
(366.40): C, 55.73; H, 3.85; N, 22.94. Found C, 55.89; H, 3.96;
N, 22.74%.
N0-(1-[4-(4-methylphenyl)-5-(nitrosoimino)-4,5-dihydro-1,3,4-
thiadiazol-2-yl]-ethylidene)benzohydrazide (10b)
Orange solid (72%); m.p. 182–4 C; IR: v 1581 (N‚O), 1643
(C‚N), 1686 (C‚O), 3448 (NH) cm1; 1H NMR (DMSO-
d6): d 2.29 (3H, s, CH3), 2.42 (3H, s, CH3), 6.62–8.08 (9H,
m, ArH’s), 10.69 (1H, s, NH); 13C NMR (DMSO-d6): d
13.4, 20.9, 121.5, 128.9, 130.1, 134.8, 140.8, 156.1, 161.4,
161.7, 164.9; MS m/z (%): 380 (M+, 65), 237 (42), 193(43),
151(26), 77(100). Anal. Calcd for C18H16N6O2S (380.42): C,
56.83; H, 4.24; N, 22.09. Found C, 56.76; H, 4.35; N, 22.01%.N0-(1-(5-oxo-4-(p-tolyl)-4,5-dihydro-1,3,4-thiadiazol-2-
yl)ethylidene)benzo-hydrazide (11b)
A solution of compound 10b (0.5 g) in xylene (20 mL) was
reﬂuxed for 15 min and the solvent was evaporated under
reduced pressure. The oil residue was triturated with petro-
leum ether (40–60 C), and the solid formed was collected
and crystallized from ethanol to give 11b as yellow solid
(78%); m.p. 232–4 C; IR: v 1666, 1708 (2C‚O), 3448(NH)
cm1; 1H NMR (DMSO-d6): d 2.26 (3H, s, CH3), 2.39 (3H,
s, CH3), 7.32–7.79 (9H, m, ArH’s), 11.17 (1H, s, NH);
13C
NMR (DMSO-d6): d 13.4, 21.3, 120.3, 130.1, 130.9, 131.4,
123.5, 134.3, 134.6, 139.7, 149.2, 156.5, 160.2, 163.1; MS m/z
(%): 353(M++1, 18), 352(M+, 43), 239(23), 119(100),
84(65). Anal. Calcd for C18H16N4O2S (352.41): C, 61.35; H,
4.58; N, 15.90. Found C, 61.33; H, 4.51; N, 15.76%.
Synthesis of N-((E)-5-((Z)-1-(2-benzoylhydrazono)ethyl)-3-
phenyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide (12a)
A mixture of 9a (1 g) in acetic acid (10 mL) and acetic anhy-
dride (5 mL) was heated for 5 min at 70 C. The reaction mix-
ture was poured onto ice water (40 mL). The solid precipitate
was collected and crystallized to give 12a as yellow solid
(71%); m.p. 198 C (EtOH); IR: v 1632, 1651, 1709 (3C‚O),
3234 (NH) cm1; 1H NMR (DMSO-d6): d 2.17 (3H, s,
CH3), 2.28 (3H, s, CH3), 2.39 (3H, s, CH3), 7.31–7.83 (9H,
m, ArH’s), 11.17 (1H, s, NH); 13C NMR (DMSO-d6): d
13.3, 25.1, 125.6, 127.8, 128.9, 129.7, 130.6, 134.5, 140.2,
146.5, 155.1, 161.2, 164.8, 174.6; MS m/z (%): 380 (M++1,
2), 379 (M+, 8), 314 (32), 278 (31), 161 (17), 105 (100),
77(75). Anal. Calcd for C19H17N5O2S (379.11): C, 60.14; H,
4.52; N, 18.46. Found C, 60.28; H, 4.64; N, 18.67%.
Synthesis of 1,3,4-thiadiazoline derivatives 13a–c
Method A
Triethylamine (0.75 mL, 5 mmol) was added dropwise with
stirring to a mixture of methyl N-phenyldithiocarbamate
(5 mmol) and the appropriate 6a–c (5 mmol) in ethanol
(20 mL) for 30 min. The resulting solid was collected and
recrystallized from ethanol to give the corresponding 13.
Method B
A mixture of the appropriate 6a–c (5 mmol) and phenylthio-
urea (0.38 g, 5 mmol) in ethanol (25 mL) was reﬂuxed for
3 h. The solid product that formed after cooling was collected
and crystallized from ethanol to give the product 13 which
proved identical in all aspects (mp, mixed mp, and spectra)
with 13 which obtained by method A.
The products 13a–c prepared together with their physical
constants are given below.
N0-(1-(4-phenyl-5-(phenylimino)-4,5-dihydro-1,3,4-thiadiazol-
2-yl)-ethylidene)-benzohydrazide (13a)
Yellow solid (73%); m.p. 194–6 C (EtOH); IR: v 1610
(C‚N), 1661 (C‚O), 3336 (NH) cm1; 1H NMR (DMSO-
d6): d 2.33 (s, 3H, CH3), 6.91–7.98 (m, 15H, ArH’s), 10.73
888 A.O. Abdelhamid et al.(s, 1H, NH); 13C NMR (DMSO-d6): d 13.5, 124.3, 126.4,
127.9, 129.1, 129.7, 129.9, 130.2, 134.4, 140.1, 147.6, 155.7,
161.3, 164.8; MS m/z (%): 414 (M++1, 3), 413 (M+, 8),
374(5), 338 (19), 306 (56), 278 (13), 161 (56), 105 (100), 77
(96), 51 (46). Anal. Calcd for C23H19N5OS (413.49): C,
66.81; H, 4.63; N, 16.94. Found C, 66.65; H, 4.54; N, 16.76%.
4-Methyl-N0-(1-(4-phenyl-5-(phenylimino)-4,5-dihydro-1,3,4-
thiadiazol-2-yl)ethyl-idene)benzohydrazide (13b)
Yellow solid (78%); m.p. 213–5 C (EtOH); IR: v 1619
(C‚N), 1670(C‚O), 3324 (NH) cm1; 1H NMR (DMSO-
d6): d 2.32 (s, 3H, CH3), 2.49 (s, 3H, CH3), 7.03–7.89 (m,
14H, ArH’s), 10.79 (s, 1H, NH); MS m/z (%): 428 (M++1,
2), 427 (M+, 5), 333 (32), 261 (5), 243 (4), 209 (17), 105
(100), 77 (70). Anal. Calcd for C24H21N5OS (427.52): C,
67.43; H, 4.95; N, 16.38. Found C, 67.33; H, 4.78; N, 16.30%.
4-Methyl-N0-(1-((Z)-5-(phenylimino)-4-(p-tolyl)-4,5-dihydro-
1,3,4-thiadiazol-2-yl)ethylidene)benzohydrazide (13c)
Yellow solid (73%); m.p. 196–8 C (EtOH); IR: v 1614
(C‚N), 1674 (C‚O), 3313 (NH) cm1; 1H NMR (DMSO-
d6): d 2.15 (s, 3H, CH3), 2.38 (s, 3H, CH3), 2.50 (s,3H,
CH3), 6.94–7.82 (m, 13H, ArH’s), 10.71 (s, 1H, NH);
13C
NMR (DMSO-d6): d 13.4, 20.8, 21.5, 121.2, 124.2, 127.8,
129.8, 131.2, 131.3, 134.2, 135.4, 145.1, 147.5, 147.8, 156.1,
161.2, 164.8; MS m/z (%): 442(M++1, 5), 441(M+, 3), 306
(9), 225 (8), 175 (15), 119 (100), 105 (27), 77 (24). Anal. Calcd
for C25H23N5OS (441.55): C, 68.00; H, 5.25; N, 15.86. Found
C, 67.70; H, 5.29; N, 15.57%.
Synthesis of 1,3,4-thiadiazoline derivatives 14a–g
Method A
Triethylamine (0.75 mL, 5 mmol) was added dropwise with
stirring to a mixture of methyl arylidenedithiocarbazate
(5 mmol) and the appropriate 6a–c (0.005 mol) in ethanol
(20 mL) for 30 min. The resulting solid was collected and crys-
tallized from DMF to give the corresponding product 14a–g.
N0-(1-(5-(benzylidenehydrazono)-4-phenyl-4,5-dihydro-1,3,4-
thiadiazol-2-yl)-ethylidene)benzohydrazide (14a)
Orange solid (86%); m.p. 268 C (DMF); IR: v 1604 (C‚N),
1663 (C‚O), 3184 (NH) cm1; 1H NMR (DMSO-d6): d 2.43
(3H, s, CH3), 7.29–8.05 (15H, m, ArH’s), 8.47 (1H, s, CH‚N),
11.25 (1H, s, NH); MS m/z (%): 442 (M++2, 4), 441 (M++1,
15), 440 (M+, 52), 323 (12), 161 (45), 105 (56), 77 (98). Anal.
Calcd for C24H20N6OS (440.52): C, 65.44; H, 4.58; N, 19.08.
Found C, 65.36; H, 4.34; N, 19.02%.
N0-(1-(5-(benzylidenehydrazono)-4-(p-tolyl)-4,5-dihydro-
1,3,4-thiadiazol-2-yl)-ethylidene)benzo-hydrazide (14b)
Orange solid (80%); m.p. 240–2 C (DMF); IR: v 1604
(C‚N), 1666 (C‚O), 3176 (NH) cm1; 1H NMR (DMSO-
d6): d 2.19 (3H, s, CH3), 2.44 (3H, s, CH3), 6.94–7.82 (14H,
m, ArH’s), 8.45 (1H, s, CH‚N), 11.23 (1H, s, NH); MS m/z
(%): 455 (M++1, 14), 454 (M+, 39), 337 (12), 161 (34), 105(100), 77 (79). Anal. Calcd for C25H22N6OS (454.55): C,
66.06; H, 4.88; N, 18.49. Found C, 66.12; H, 4.67; N, 18.39%.
N0-(1-(5-(benzylidenehydrazono)-4-(p-tolyl)-4,5-dihydro-1,3,4-
thiadiazol-2-yl)-ethylidene)-4-methylbenzohydrazide (14c)
Orange solid (83%); m.p. 278 C (DMF); IR: v 1610 (C‚N),
1659 (C‚O), 3172 (NH) cm1; 1H NMR (DMSO-d6): d 2.51
(3H, s, CH3), 3.30 (3H, s, CH3), 7.17–7.89 (13H, m, ArH’s),
8.34 (1H, s, CH‚N), 11.15 (1H, s, NH); MS m/z (%): 455
(M++1, 14), 454 (M+, 39), 337 (12), 161 (34), 105 (100), 77
(79). Anal. Calcd for C26H24N6OS (468.57): C, 66.64; H,
5.16; N, 17.94. Found C, 66.69; H, 5.12; N, 17.72%.
N0-(1-(5-((4-chlorobenzylidene)hydrazono)-4-phenyl-4,5-
dihydro-1,3,4-thiadiazol-2-yl)ethylidene)benzohydrazide (14d)
Yellow solid (84%); m.p. 274–6 C (DMF); IR: v 1610 (C‚N),
1663 (C‚O), 3177 (NH) cm1; 1H NMR (DMSO-d6): d 2.49
(3H, s, CH3), 7.34–8.04 (14H, m, ArH’s), 8.47 (1H, s, CH‚N),
11.25 (1H, s, NH); MS m/z (%): 477 (M++2, 3), 475 (M++1,
10), 474 (M+, 10), 161 (30), 105 (100), 77 (68). Anal. Calcd for
C24H19ClN6OS (474.97): C, 60.69; H, 4.03; 7.46; N, 17.69.
Found C, 60.47; H, 4.01; N, 17.53%.
N0-(1-(5-((4-nitrobenzylidene)hydrazono)-4-phenyl-4,5-
dihydro-1,3,4-thiadiazol-2-yl)ethylidene) benzohydrazide (14e)
Orange solid (83%); m.p. 260 C (DMF); IR: v 1604 (C‚N),
1663 (C‚O), 3187 (NH) cm1; 1H NMR (DMSO-d6): d 2.31
(3H, s, CH3), 7.22–7.90 (14H, m, ArH’s), 8.44 (1H, s, CH‚N),
11.27 (1H, s, NH); 13C NMR (DMSO-d6): d 13.4, 20.9, 21.6,
119.4, 124.7, 127.9, 129.8, 131.2, 132.4, 133.4, 134.9, 138.1,
144.3, 145.1, 154.9, 158.8, 160.4, 161.3, 164.8; MS m/z (%):
486 (M++1, 8), 485 (M+, 25), 290 (31), 262 (11), 105 (100),
77 (66). Anal. Calcd for C24H19N7O3S (485.52): C, 59.37; H,
3.94; N, 20.19. Found C, 59.30; H, 3.87; N, 20.03%.
N0-(1-(5-((4-chlorobenzylidene)hydrazono)-4-(p-tolyl)-4,5-
dihydro-1,3,4-thiadiazol-2-yl)ethylidene)-4-
methylbenzohydrazide (14f)
Orange solid (80%); m.p. 318 C (DMF); IR: v 1608 (C‚N),
1660 (C‚O), 3172 (NH) cm1; 1H NMR (DMSO-d6): d 2.33
(3H, s, CH3), 2.43 (3H, s, CH3), 3.34 (3H, s, CH3), 7.27–7.90
(12H, m, ArH’s), 8.45 (1H, s, CH‚N), 11.26 (1H, s, NH);
MS m/z (%): 504 (M++1, 19), 503 (M+, 29), 297 (39), 262
(19), 119 (100), 105 (75), 77 (41). Anal. Calcd for C26H23ClN6-
OS (503.02): C, 62.08; H, 4.61; N, 16.71. Found C, 62.01; H,
4.54; N, 16.24%.
4-Methyl-N0-(1-(5-((4-nitrobenzylidene)hydrazono)-4-(p-
tolyl)-4,5-dihydro-1,3,4-thiadiazol-2-
yl)ethylidene)benzohydrazide (14g)
Orange solid (84%); m.p. 292 C (DMF); IR: v 1591 (C‚N),
1661 (C‚O), 3171 (NH) cm1; 1H NMR (DMSO-d6): d 2.37
(3H, s, CH3), 2.49 (3H, s, CH3), 3.32 (3H, s, CH3), 7.32–7.89
(12H, m, ArH’s), 8.44 (1H, s, CH‚N), 11.14 (1H, s, NH);
MS m/z (%): 514 (M++1, 5), 513 (M+, 14), 119 (100), 105
Scheme 2
Synthesis of new functionalized 1,3,4-thiadiazoles 889(6), 77 (5). Anal. Calcd for C26H23N7O3S (513.57): C, 60.81; H,
4.51; N, 19.09. Found C, 60.67; H, 4.59; N, 19.01%.
Method B
A mixture of 15a (0.35 g, 1 mmol) and benzaldehyde (0.106 g,
1 mmol) in isopropyl alcohol (15 mL) was reﬂuxed for 30 min.
The solid product that formed after cooling was collected and
crystallized from acetic acid to give a product proved identicalSchemein all aspects (mp, mixed mp, and spectra) with 14a which was
obtained by method A.
Synthesis of N0-(1-(5-hydrazono-4-phenyl-4,5-dihydro-1,3,4-
thiadiazol-2-yl)-ethylidene)benzohydrazide 15a
Triethylamine (0.75 mL, 5 mmol) was added dropwise with
stirring to a mixture of methyl dithiocarbazate (0.61 g,
5 mmol) and 6a (0.98 g, 5 mmol) in ethanol (20 mL) for
30 min. The resulting solid was collected and recrystallized
from ethanol to give 15a as a yellow solid (79%); m.p. 242–
4 C; IR: v 1600(C‚N), 1647 (C‚O), 3184, 3435 (NH2,
NH) cm1; 1H NMR (DMSO-d6): d 2.18 (3H, s, CH3),
6.90–7.90 (12H, m, ArH’s, NH2), 10.25 (1H, s, NH); MS m/z
(%): 353(M++1, 2), 352 (M+, 12), 284 (13), 174 (14), 105
(51), 55 (100). Anal. Calcd for C17H16N6OS (352.41): C,
57.94; H, 4.58; N, 23.85. Found C, 57.78; H, 4.45; N, 23.78%.
Synthesis of N0-(1-(5-(2-benzoylhydrazono)-4-aryl-4,5-
dihydro-1,3,4-thiadiazol-2-yl)-ethylidene)-benzohydrazides
16a,b
Method A
Triethylamine (0.75 mL, 5 mmol) was added dropwise with
stirring to a mixture of methyl 2-benzoylhydrazinecarbodithio-
ate (1.13 g, 5 mmol) and the equimolar amount of 6a,b
(5 mmol) in ethanol (20 mL). The resulting solid, which
formed after 30 min, was collected and crystallized from
DMF to give the corresponding product 16.3
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Triethylamine (0.75 mL, 5 mmol) was added dropwise with
stirring to a mixture of 5-phenyl-1,3,4-oxadiazole-2-thiol
(0.89 g, 5 mmol) and the equimolar amount of 6a,b (5 mmol)
in ethanol (20 mL). The resulting solid, which formed after
6 h, was collected and recrystallized from DMF to give the cor-
responding product 16 in 82% yield as in method A.
N0-(1-(5-(2-benzoylhydrazono)-4-phenyl-4,5-dihydro-1,3,4-
thiadiazol-2-yl)-ethylidene)-benzohydrazide (16a)
Orange solid (82%); m.p. 284–6 C (DMF); IR: v 1647
(C‚O), 3175, 3448 (2NH) cm1; 1H NMR (DMSO-d6): d
2.34 (s, 3H, CH3), 7.11–7.80 (m, 15H, ArH’s), 8.98 (s, 1H,
br, NH), 11.10 (1H, s, br, NH); MS m/z (%): 457 (M++1,
76), 456 (M+, 57), 290 (97), 225 (100), 192 (95), 116 (93), 53
(55). Anal. Calcd for C24H20N6O2S (456.52): C, 63.14; H,
4.42; N, 18.41. Found C, 63.11; H, 4.35; N, 18.32%.
N0-(1-(5-(2-benzoylhydrazono)-4-(p-tolyl)-4,5-dihydro-1,3,4-
thiadiazol-2-yl)-ethylidene)-benzohydrazide (16b)
Orange solid (85%); m.p. 216–8 C (DMF); IR: v 1655
(C‚O), 3187, 3441 (2NH) cm1; 1H NMR (DMSO-d6): d
2.21 (s, 3H, CH3), 2.36 (s, 3H, CH3), 7.19–7.96 (m, 14H,
ArH’s), 9.08 (s, br, 1H, NH), 11.17 (s, br, 1H, NH); 13C
NMR (DMSO-d6): d 11.4, 20.8, 119.3, 126.4, 127.8, 128.7,
129.3, 132.6, 133.4, 134.4, 140.1, 153.2, 158.5, 162.4, 164.4,
165.7; MS m/z (%): 471 (M++1, 38), 470 (M+, 28), 403
(39), 286 (43), 206 (39), 137 (54), 105 (72), 77 (100). Anal.
Calcd for C25H22N6O2S (470.55): C, 63.81; H, 4.71; N,
17.86. Found C, 63.68; H, 4.67; N, 17.67%.
Antimicrobial assay
The biological evaluation was carried out in the Medical
Mycology Laboratory of the Regional Center for Mycology
and Biotechnology of Al-Azhar University, Cairo, Egypt.
The method adopted for such tests is the Agar diffusion
method. The microorganism inoculums were uniformly spread
using sterile cotton swab on a sterile Petri dish Malt extractSchemeagar (for fungi) and nutrient agar (for bacteria). One hundred
lL of each sample was added to each well (10 mm diameter
holes cut in the agar gel, 20 mm apart from one another).
The systems were incubated for 24–48 h at 37 C (for bacteria)
and at 28 C (for fungi). After incubation, the microorganism’s
growth was observed. Inhibition of the bacterial and fungal
growth was measured as IZD in mm. Tests were performed
in triplicate [25].Results and discussion
In our hands, reaction of benzoylhydrazine with each of the
hydrazonoyl chlorides 2b in reﬂuxing ethanol yielded, in each
case, the corresponding condensation product 6 as previously
reported [18]. The structures of the latter products were
conﬁrmed by their chemical reaction as outlined below.
Treatment of 6 each with sodium thiophenolate afforded
phenyl 2-(2-benzoylhydrazono)-N0-phenylpropanehydrazono-
thioate 7 (Scheme 2). The latter product 7 was alternatively
prepared by reacting the hydrazonoyl chloride 2b with sodium
thiophenolate to give phenyl 2-oxo-N0-phenylpropanehydrazo-
nothioate 8 and treatment of the latter with benzoylhydrazine
(Scheme 2).
Next, reactions of 6 with various sulfur reagents were exam-
ined. Thus, treatment of each of compounds 6a, b with potas-
sium thiocyanate in ethanol gave the corresponding 1,3,4-
thiadiazoline derivatives 9a,b, respectively. The structures of
the latter products 9a, b were elucidated based on their elemen-
tal and spectral analyses (IR, MS and 1H NMR) (see Experi-
mental). In addition, structure 9 was conﬁrmed by alternate
synthesis. Thus, treatment of 6 with thiourea in ethanol affor-
ded products identical in all respects with the product obtained
by reaction of 6 with potassium thiocyanate (Scheme 3). Fur-
thermore, the assigned structure 9 was conﬁrmed by its chem-
ical reactions. For example, treatment of 9a,b each with
sodium nitrite in acetic acid yielded the corresponding N-
nitroso derivatives 10a,b, respectively. Heating of 10b in xylene
gave the thiadiazolone derivative 11b. In addition, treatment
of 9a with acetyl chloride yielded the corresponding N-acetyl
derivative 12a (Scheme 3).4
Scheme 5
Synthesis of new functionalized 1,3,4-thiadiazoles 891Reaction of 6a–c each with either methyl N-phenyldithioc-
arbamate or phenylthiourea in ethanol yielded in both cases
one and same product that proved to be the corresponding
2-phenyliminothiadizoline derivative 13 (Scheme 4). The struc-
tures of the isolated products 13a–c were elucidated based on
their elemental and spectral analyses (see Experimental). For
example, the infrared spectrum of 13a showed bands at v
3336 (NH), 1661 (C‚O), 1610 (C‚N) cm1 and their 1HSchemeNMR, in addition to the aromatic proton signals, revealed
characteristic signals at d 2.33 (CH3) and 10.73 (NH).
Reaction of 6 with methyl 2-(4-substituted benzyli-
dene)hydrazinecarbodithioate in ethanol in the presence of tri-
ethylamine afforded, in each case, one isolable product that
was identiﬁed based upon its spectral (IR, MS and 1H
NMR) and elemental analyses as the corresponding thiadiazo-
line derivative 14 (Scheme 5) (see Experimental). Structure 146
Table 1 Antibacterial activity of the synthesized compounds (9–16).*
Compounds Minimal inhibitory concentration in lg/mL (zone of inhibition in mm)
Gram-positive bacteria Gram-negative bacteria
Staphylococcus pneumoniae Bacillis subtilis Pseudomonas aeruginosa Escherichia coli
9a 16.8 ± 0.37 15.9 ± 0.44 NA 12.6 ± 0.25
10a 15.8 ± 0.44 14.2 ± 0.37 NA 12.0 ± 0.58
11a 18.2 ± 0.44 20.2 ± 0.58 NA 18.0 ± 0.25
12a 19.2 ± 0.17 20.8 ± 0.29 NA 19.5 ± 0.42
13a 16.2 ± 0.44 15.3 ± 0.44 NA 12.8 ± 0.25
13b 16.3 ± 0.44 21.0 ± 0.37 NA 18.0 ± 0.44
14a 13.7 ± 0.44 15.0 ± 0.37 NA 10.0 ± 0.44
14b 9.4 ± 0.37 12.1 ± 0.19 NA 8.3 ± 037
16a 13.8 ± 0.44 17.2 ± 0.25 NA 10.7 ± 0.25
16b 16.5 ± 0.44 21.4 ± 0.37 NA 19.7 ± 0.44
Ampicillin 23.8 ± 0.2 32.4 ± 0.3 – –
Gentamicin – – 17.3 ± 0.1 19.9 ± 0.3
*
NA: No activity, data are expressed in the form of mean ± SD.
892 A.O. Abdelhamid et al.was conﬁrmed by alternate synthesis. Thus, reaction of 6a with
methyl dithiocarbazate in ethanol in the presence of triethyl-
amine yielded the thiadiazoline derivative 15a. Treatment of
the latter with benzaldehyde in ethanol afforded product that
proved identical in all respects (mp., mixed mp., IR, 1H
NMR) with 14a obtained above (Scheme 5).
Similar reaction of 6a,b each with methyl 2-benzoylhydra-
zinecarbodithioate yielded the thiadiazoline derivatives 16a,b,
respectively (Scheme 6). The structures of the latter were eluci-
dated based on by elemental and spectral analyses and also by
alternate syntheses (see Experimental). Thus, treatment of 6a,b
each with 5-phenyl-1,3,4-oxadiazole-2-thione in reﬂuxing etha-
nol in the presence of triethylamine afforded products that
proved identical in all aspects (mp., mixed mp., and spectra)
with those 16a,b obtained from the foregoing reaction of 6a,b
with methyl 2-benzoylhydrazinecarbodithioate (Scheme 6).
Antimicrobial activity
The newly synthesized compounds 9a, 10a, 11a, 12a, 13a,b,
14a,b, and 16a,b were tested for their in vitro antibacterial
activity against two Gram-positive bacteria namely Staphylo-
coccus pneumoniae (SP) and Bacillis subtilis (BS) and two
Gram-negative bacteria namely Pseudomonas aeruginosa
(PA) and Escherichia coli (EC). They were also tested for theirTable 2 Antifungal activity of the synthesized compounds (9–16).*
Compounds Minimal inhibitory conce
Aspergillus fumigatus Syncephalastrum
9a 15.7 ± 0.44 17.4 ± 0.25
10a 14.2 ± 0.44 15.8 ± 0.58
11a 17.9 ± 0.22 19.9 ± 0.44
12a 18.9 ± 0.22 20.2 ± 0.25
13a 14.9 ± 0.58 16.4 ± 0.19
13b 18.3 ± 0.44 19.9 ± 0.58
14a 13.3 ± 0.25 12.4 ± 0.44
14b 9.3 ± 0.15 8.3 ± 0.19
16a 13.4 ± 0.58 12.7 ± 0.37
16b 19.3 ± 0.44 20.0 ± 0.58
Amphotericin B 23.7 ± 0.1 19.7 ± 0.2
*
NA: No activity, data are expressed in the form of mean ± SD.in vitro antifungal activity against three fungi species namely
Aspergillus fumigatus (AF), Geotrichum candidum (GC), Can-
dida albicans (CA) and Syncephalastrum racemosum (SR).
The organisms were tested against the activity of solutions of
concentration (5 lg/mL) of each compound and using inhibi-
tion zone diameter (IZD) in mm as criterion for the antimicro-
bial activity (agar diffusion well method). The fungicides
Amphotericin B and the bactericides Ampicillin, Gentamicin
were used as references to evaluate the potency of the tested
compounds under the same conditions. The results are summa-
rized in Tables 1 and 2. Such results indicate the following: (1)
Compounds 9a, 10a, 11a, 12a, 13a, 13b, 14a and 16b exhibit
high inhibitory effects against of S. pneumoni, (2) Compounds
9a, 10a, 11a, 12a, 13a, 13b, 14a, 14b, 16a and 16b exhibit high
inhibitory effects against of B. subtilis while have no inhibitory
effect toward P. aeruginosa, (3) Compounds 11a, 12a, 13b and
16b exhibit high inhibitory effects against E. coli, (4) Com-
pound 14b has moderate inhibitory effect against S. pneumo-
niae. On the other hand, compounds 9a, 10a, 13a, 14a, 14b,
and 16a have moderate inhibitory effect toward E. coli and
(5) Compounds 9a, 10a, 11a, 12a, 13a, 13b, 14a, 14b, 16a
and 16b exhibit high inhibitory activities against each of A.
fumigatus, S. racemosum and G. candidum, while compound
14b has moderate inhibitory activity and all compounds have
no activity against C. albicans.ntration in lg/Ml (zone of inhibition in mm)
racemosum Geotrichum candidum Candida albicans
13.9 ± 0.32 NA
12.4 ± 0.4 NA
16.8 ± 0.44 NA
16.8 ± 0.44 NA
14.7 ± 0.25 NA
18.0 ± 0.19 NA
13.6 ± 0.44 NA
13.3 ± 0.38 NA
14.3 ± 0.58 NA
18.2 ± 0.19 NA
28.7 ± 0.2 25.4 ± 0.1
Synthesis of new functionalized 1,3,4-thiadiazoles 893Conclusion
In conclusion, reaction of acylhydrazines with a-ketohydrazo-
noyl chlorides yielded the condensation products 6. The latter
products 6 proved to be useful precursors for synthesis of vari-
ous functionalized 1,3,4-thiadiazole derivatives. The structures
of the newly synthesized compounds were conﬁrmed by spectral
data, elemental analyses and alternate syntheses. Most of the
compounds prepared exhibit considerable antimicrobial
activities.
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